Brief: Pure Biologics Says All 0.6 Mln E Series Shares Allocated
10/12/2020 09:01
Dec 10 (Reuters) - Pure Biologics SA PUR1.WA :
* SAYS ALL 0.6 MILLION E SERIES SHARES ALLOCATED AT ISSUE
PRICE 90
ZLOTYS PER SHARE
* SAYS INDIVIDUAL INVESTOR TRANCHE REDUCTION RATE AT 91.28%
FOR E
SERIES SHARES
Source text for Eikon: ID:nEBbGmyHn
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects